Literature DB >> 19679876

A novel organotypic model mimics the tumor microenvironment.

Sini Nurmenniemi1, Teemu Sinikumpu, Ilkka Alahuhta, Sirpa Salo, Meeri Sutinen, Markku Santala, Juha Risteli, Pia Nyberg, Tuula Salo.   

Abstract

Carcinoma cell invasion is traditionally studied in three-dimensional organotypic models composed of type I collagen and fibroblasts. However, carcinoma cell behavior is affected by the various cell types and the extracellular matrix (ECM) in the tumor microenvironment. In this study, a novel organotypic model based on human uterine leiomyoma tissue was established and characterized to create a more authentic environment for carcinoma cells. Human tongue squamous cell carcinoma cells (HSC-3) were cultured on top of either collagen or myoma. Organotypic sections were examined by immunohistochemistry and in situ hybridization. The maximal invasion depth of HSC-3 cells was markedly increased in myomas compared with collagen. In myomas, various cell types and ECM components were present, and the HSC-3 cells only expressed ECM molecules in the myoma model. Organotypic media were analyzed by radioimmunoassay, zymography, or Western blotting. During carcinoma cell invasion, matrix metalloprotease-9 production and collagen degradation were enhanced particularly in the myoma model. To evaluate the general applicability of the myoma model, several oral carcinoma, breast carcinoma, and melanoma cell lines were cultured on myomas and found to invade in highly distinct patterns. We conclude that myoma tissue mimics the native tumor microenvironment better than previous organotypic models and possibly enhances epithelial-to-mesenchymal transition. Thus, the myoma model provides a promising tool for analyzing the behavior of carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679876      PMCID: PMC2731146          DOI: 10.2353/ajpath.2009.081110

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  cDNA clones coding for the pro-alpha1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain.

Authors:  T Pihlajaniemi; K Tryggvason; J C Myers; M Kurkinen; R Lebo; M C Cheung; D J Prockop; C D Boyd
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Type I collagen degradation by invasive oral squamous cell carcinoma.

Authors:  B L Ziober; M A Turner; J M Palefsky; M J Banda; R H Kramer
Journal:  Oral Oncol       Date:  2000-07       Impact factor: 5.337

4.  Growth of malignant oral epithelial stem cells after seeding into organotypical cultures of normal mucosa.

Authors:  Ian C Mackenzie
Journal:  J Oral Pathol Med       Date:  2004-02       Impact factor: 4.253

Review 5.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

6.  Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.

Authors:  Pia Nyberg; Pia Heikkilä; Timo Sorsa; Jani Luostarinen; Ritva Heljasvaara; Ulf-Håkan Stenman; Taina Pihlajaniemi; Tuula Salo
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

7.  Effects of 12-O-tetradecanoylphorbol 13-acetate on the production of mRNAs for human tissue-type plasminogen activator.

Authors:  G Opdenakker; H Ashino-Fuse; J Van Damme; A Billiau; P De Somer
Journal:  Eur J Biochem       Date:  1983-04-05

8.  Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo.

Authors:  N E Fusenig; D Breitkreutz; R T Dzarlieva; P Boukamp; A Bohnert; W Tilgen
Journal:  J Invest Dermatol       Date:  1983-07       Impact factor: 8.551

9.  Increased expression of collagen types I and III in human skin as a consequence of radiotherapy.

Authors:  Riitta Riekki; Mataleena Parikka; Arja Jukkola; Tuula Salo; Juha Risteli; Aarne Oikarinen
Journal:  Arch Dermatol Res       Date:  2002-04-27       Impact factor: 3.017

Review 10.  The role of endothelial-to-mesenchymal transition in cancer progression.

Authors:  S Potenta; E Zeisberg; R Kalluri
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  34 in total

1.  The role of the tumour microenvironment in the biology of head and neck cancer: lessons from mobile tongue cancer.

Authors:  Marilena Vered; Dan Dayan; Tuula Salo
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

Review 2.  Developments in preclinical cancer imaging: innovating the discovery of therapeutics.

Authors:  James R W Conway; Neil O Carragher; Paul Timpson
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

3.  Role of RNA binding protein HuR in ductal carcinoma in situ of the breast.

Authors:  Mira Heinonen; Annabrita Hemmes; Kaisa Salmenkivi; Kotb Abdelmohsen; Suvi-Tuuli Vilén; Marko Laakso; Marjut Leidenius; Tuula Salo; Sampsa Hautaniemi; Myriam Gorospe; Päivi Heikkilä; Caj Haglund; Ari Ristimäki
Journal:  J Pathol       Date:  2011-04-11       Impact factor: 7.996

4.  Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.

Authors:  Silvia Montoro-García; Begoña Alburquerque-González; Ángel Bernabé-García; Manuel Bernabé-García; Priscila Campioni Rodrigues; Helena den-Haan; Irene Luque; Francisco José Nicolás; Horacio Pérez-Sánchez; María Luisa Cayuela; Tuula Salo; Pablo Conesa-Zamora
Journal:  J Mol Med (Berl)       Date:  2020-01-29       Impact factor: 4.599

Review 5.  Engineering approaches to studying cancer cell migration in three-dimensional environments.

Authors:  Noam Zuela-Sopilniak; Jan Lammerding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

Review 6.  Extracellular matrix determinants and the regulation of cancer cell invasion stratagems.

Authors:  A L Willis; F Sabeh; X-Y Li; S J Weiss
Journal:  J Microsc       Date:  2013-09       Impact factor: 1.758

Review 7.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

8.  Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.

Authors:  Léon C van Kempen; Karin van den Hurk; Vladimir Lazar; Stefan Michiels; Véronique Winnepenninckx; Marguerite Stas; Alan Spatz; Joost J van den Oord
Journal:  Virchows Arch       Date:  2012-09-06       Impact factor: 4.064

9.  Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway.

Authors:  J O Humtsoe; R H Kramer
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

10.  Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.

Authors:  Dan Dayan; Tuula Salo; Sirpa Salo; Pia Nyberg; Sini Nurmenniemi; Daniela Elena Costea; Marilena Vered
Journal:  Cancer Med       Date:  2012-08-16       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.